Place, David E.

ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways

Kuriakose, T., Man, S. M., Subbarao Malireddi, R. K., Karki, R., Kesavardhana, S., Place, D. E., Neale, G., Vogel, P., & Kanneganti, T.-D. (2016) · Science Immunology

interferon and immune responsesInflammasome and immune disorders

Cited by 818

Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)

Christgen, S., Zheng, M., Kesavardhana, S., Karki, R., Malireddi, R. K. S., Banoth, B., Place, D. E., Briard, B., Sharma, B. R., Tuladhar, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology

Cell death mechanisms and regulationInflammasome and immune disorders

Cited by 588

IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes

Man, S. M., Karki, R., Sasai, M., Place, D. E., Kesavardhana, S., Temirov, J., Frase, S., Zhu, Q., Malireddi, R. K. S., Kuriakose, T., et al. (2016) · Cell

Inflammasome and immune disordersImmune Response and Inflammation

Cited by 312

First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers

Tang, F., Kunder, R., Chu, T., Hains, A., Nguyen, A., McBride, J. M., Zhong, Y., Santagostino, S., Wilson, M., Trenchak, A., et al. (2023) · Clinical and Translational Science

Inflammasome and immune disordersPharmacogenetics and Drug Metabolism

Cited by 70

ASK Family Kinases Are Required for Optimal NLRP3 Inflammasome Priming

Place, D. E., Samir, P., Karki, R., Briard, B., Vogel, P., & Kanneganti, T.-D. (2018) · The American Journal of Pathology

Inflammasome and immune disordersImmune Response and Inflammation

Cited by 22